Financhill
Sell
44

CVAC Quote, Financials, Valuation and Earnings

Last price:
$3.49
Seasonality move :
-9.32%
Day range:
$3.40 - $3.59
52-week range:
$2.37 - $5.28
Dividend yield:
0%
P/E ratio:
4.29x
P/S ratio:
1.33x
P/B ratio:
1.08x
Volume:
619.1K
Avg. volume:
662.4K
1-year change:
16.44%
Market cap:
$781.3M
Revenue:
$579.3M
EPS (TTM):
$0.55

Earnings Data

Next earnings date for CVAC
May 23
2025
Most recent earnings per share
-$0.16
Missed by $0.07
(Dec 31/2024)
Consensus Estimate
-$0.09
(Dec 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CVAC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $39.2M -- -- $0.10 --
04/10/2025 Q1 $3.8M -- -- -$0.21 --
12/31/2024 Q4 $21.4M $15.4M -$0.16 -$0.09 -$0.07
11/12/2024 Q3 $150.6M $543.2M $1.65 $1.54 $0.11
08/15/2024 Q2 $5.4M $15.5M -$0.34 -$0.28 -$0.06
05/23/2024 Q1 $13.7M $13.4M -$0.34 -$0.22 -$0.11
12/31/2023 Q4 $31.5M $24.3M -$0.42 -$0.15 -$0.27
11/14/2023 Q3 -- -- -$0.24 -$0.23 -$0.01
08/17/2023 Q2 -- -- -$0.33 -$0.25 -$0.07
05/30/2023 Q1 -- -- -$0.29 -$0.37 $0.08
12/31/2022 Q4 -- -- -$0.70 -$0.29 -$0.41
09/30/2022 Q3 -- -- -$0.25 -$0.25 -$0.01
08/18/2022 Q2 -- -- -$0.33 -$0.33 -$0.00
05/25/2022 Q1 -- -- -$0.09 -- --
12/31/2021 Q4 -- -- -- -$0.98 --
11/19/2021 Q3 -- -- -$0.91 -- --
08/16/2021 Q2 -- -- -$0.99 -$1.01 $0.02
05/26/2021 Q1 -- -- -$0.75 -$0.92 $0.17
12/31/2020 Q4 -- -- -$0.38 -$0.61 $0.24
11/30/2020 Q3 -- -- -$0.24 -$0.88 $0.64
06/30/2020 Q2 -- -- -$0.06 -- --
03/31/2020 Q1 -- -- -$0.15 -- --
12/31/2019 Q4 -- -- -$0.23 -- --
09/30/2019 Q3 -- -- -$0.12 -- --
03/31/2019 Q1 -- -- -$0.14 -- --

CureVac NV Earnings Questions

  • How Much did CureVac NV Generate in Revenue Last Quarter?

    CureVac NV reported $15.4M worth of top line sales in its most recent quarter.

  • Did CureVac NV Beat Earnings Last Quarter?

    CureVac NV announced earnings per share of -$0.16 which represents a miss of analyst forecast a -$0.09 per share.

  • Is CureVac NV Profitable?

    CureVac NV reported $519.1M that represents $2.30 per share over the last quarter.

  • What is the Analyst Consensus for CureVac NV EPS Next Year?

    CureVac NV's earnings are forecast to decrease from $0.78 per share to $0.87 per share next year representing a decrease of -82.84%.

  • When is CureVac NV's Earnings Date?

    CureVac NV's next earnings date is May 23, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 10

Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.

Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock